Vanderbilt-Ingram Cancer Center

The study team included, from left, Paula Gonzalez-Ericsson, MD, Xiaopeng Sun, Justin Balko, PharmD, PhD, and Brandie Taylor, MS. (photo by Donn Jones)

Vulnerability found in immunotherapy-resistant triple-negative breast cancer

Vanderbilt researchers have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.

From left, Mark Evers, MD; Seth Carp, MD; Robert Coffey, MD; Carmen Solórzano, MD; J. Joshua Smith, MD, PhD; Naji N. Abumrad, MD; Steven Leach, MD; and Paula Marincola Smith, MD, PhD, pose for a photo during the R. Daniel Beauchamp Memorial Symposium at Vanderbilt University Medical Center. Not pictured, David Hanna, MD. (hoto by Erin O. Smith)

Beauchamp honored at symposium highlighting basic research by surgeon scientists

The profound impact of R. Daniel Beauchamp, MD, former chair of the Section of Surgical Sciences at Vanderbilt University Medical Center, was deeply evident at a recent symposium highlighting basic research conducted by numerous surgeons and physician-scientists, all of whom were closely associated with the noted physician-scientist.

Study finds new genetic susceptibilities for colon cancer

Vanderbilt researchers at have found new genes that put people at higher risk for colon cancer and rectal cancer. 

Houra Merrikh and Juan Carvajal-Garcia, PhD, are studying how to prevent cancer therapy resistance. (photo by Erin O. Smith)

Foundation funds research to block drug resistance in cancer treatment

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance.

A probe-based system developed by a team at Vanderbilt University and Vanderbilt University Medical Center uses near-infrared autofluorescence to confirm the location of parathyroid tissue during surgery.

Study shows Vanderbilt-developed technology assists surgeons in identifying parathyroids

A team of surgeons and biomedical engineers have shown the use of probe-based near infrared autofluorescence technology helps confirm the identification of parathyroid glands during endocrine surgery

The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)

Vanderbilt-Ingram Cancer Center hosts Korean American Symposium

Vanderbilt-Ingram Cancer Center recently hosted the first of a planned series of events to highlight the diversity of oncology researchers and to nurture networking opportunities for them.

1 4 5 6 7 8 26